Camonsertib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Camonsertib, covering 2025-10-21 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma [Phase 1]